Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
5,733,102
-
Share change
-
+1,850,114
-
Total reported value
-
$204,044,462
-
Price per share
-
$35.59
-
Number of holders
-
58
-
Value change
-
+$64,175,230
-
Number of buys
-
22
-
Number of sells
-
24
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2019
As of 30 Sep 2019 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,733,102 shares of stock of the company.
Largest 10 holders included CREDIT SUISSE AG/, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, Wharton Business Group, LLC, Hochman Cole Investment Advisors, Inc., WELLS FARGO & COMPANY/MN, LPL Financial LLC, and BARCLAYS PLC.
This table shows 58 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.